Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC Sponsored ADR ( (HLN) ) has issued an announcement.
On January 17, 2025, Haleon PLC announced that Pfizer Inc. has reduced its stake in the company by selling 700 million ordinary shares through a secondary offering. This sale significantly decreased Pfizer’s voting rights in Haleon from 15.04% to 7.31%, impacting the company’s shareholder structure and potentially influencing its future strategic decisions.
More about Haleon PLC Sponsored ADR
Haleon PLC operates in the consumer healthcare industry, providing a range of health-focused products and services. The company is known for its market focus on over-the-counter medicinal products, offering solutions for everyday health needs.
YTD Price Performance: -2.65%
Average Trading Volume: 7,073,409
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $40.95B
Find detailed analytics on HLN stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “More Hopeful than Real”: Is a Bidding War Brewing for Warner Bros. Discovery Stock (NASDAQ:WBD)?
- “Didn’t Develop the Way Automakers Thought.” Ford Notches Up, Reconsidering the EV Market
- “Our Focus is Increasingly…on Inference”: Intel Stock (NASDAQ:INTC) Jumps With Crescent Island Testing Next Year